Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population
Pediatric Pulmonology · 2026-03 · 61 (3)
DOI: 10.1002/ppul.71508 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Pulmonology, online erschienen am 27.02.2026. Verfasst von Heather Boas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, National Institute of Health, NHLBI NIH HHS.
Abstract (Originalsprache)
Respiratory oscillometry is a test performed during normal tidal breathing, making it an ideal test of lung function for children too young to co-ordinate the maneuvers required for spirometry [1]. The arrival of commercial devices has seen increasing interest in oscillometry as a test of respiratory system function; however, its integration into routine clinical care has been slow. There are several potential explanations for this reluctance to fully embrace oscillometry in clinical pulmonary function laboratories. Clinicians are more familiar with the spirometric and plethysmographic values of forced expiratory volume in 1 second, vital capacity, and resistance than certain parameters reflecting respiratory system high-frequency oscillation mechanics, such as reactance or resonant frequency. The latter occurs at frequencies much higher than normal, or even abnormal, breathing frequencies, making its clinical relevance seem remote. In addition, the mathematics of oscillation mechanics can be daunting, as it relies on “complex numbers” with a real (resistive) and imaginary (reactive, encompassing both elastic and inertial properties) components. A recent publication attempts to present these concepts in a more intuitive way [2]. Another potential barrier to clinical implementation of oscillometry has been the lack of robust reference equations that generate normal predicted values accounting for growth from childhood to adulthood. How to best report results compared to normal, as percent predicted values versus z-scores can also differ between pulmonary function laboratories. In addition, there are a number of different devices used in clinical care and research; these generate differing oscillatory signals, which may affect the results obtained. The recent publication of equipment-specific reference equations by Ducharme et al. for one such commercial device, the Tremoflo C-100, which was derived from a large cohort of children aged 3–17 years of age at a single center in Montreal, Canada [3], represented an important step forward, as the first equipment-specific pediatric equations for that device. However, the generalizability of these reference equations to other pediatric cohorts remains unclear. Generalizability of predicted equations to different local populations has been discussed extensively in the context of the Global Lung Function (GLI) initiative for spirometry [4]. We therefore explored the applicability of the Montreal reference equations to a local healthy control population, aged 4–18 years, tested at the Children's Hospital of Philadelphia in Philadelphia, USA. Oscillometry was performed on a cohort of 80 healthy subjects using the same model Tremoflo device as was used in the Ducharme study. Approval was obtained by the Children's Hospital of Philadelphia Institutional Review Board (IRB 20-018357_PERC). Parents or guardians provided written informed consent, and children aged 8 years and older provided assent for study participation. Airwave oscillometry was performed using the Tremoflo C-100 (Thorasys Thoracic Medical Systems Inc., Montreal, QC, Canada), according to European Respiratory Society (ERS) guidelines [5]. Before testing each subject, a device calibration check was performed according to the manufacturer's guidelines. During testing, subjects sat upright and comfortably, wearing nose clips, with their chins in “sniffing” position and with their cheeks supported. A minimum of three to five 30-second trials were performed until at least three trials were obtained with a visually observed and recorded regular respiratory pattern, with no evidence of artifact (air leak, mouthpiece occlusion by tongue, coughing, or other glottic closure). Test results were reviewed to ensure satisfaction of ERS guidelines with a coefficient of variation 97%ile) from their study, while ours did not; our Philadelphia cohort did have a higher mean weight and BMI and wider ranges as compared to the Montreal cohort (Table 1), and 12 subjects (15%) had BMI > 97%ile. However, we think that if anything, this should have caused higher resistance and more negative reactance in the Philadelphia cohort; we found the opposite. Race and ethnicity differences between the two cities could provide a possible explanation. However, while height was shown to be a significant predictor in Ducharme's oscillometry predicted equations, race and ethnicity were not. Socioeconomic factors and environmental exposures are also likely different between the two groups, which could lead to changes in lung function even in individuals considered healthy. Finally, there may be possible between device differences in Tremoflo C100 equipment. A limitation of the present work is that it is a relatively small sample from a single institution. The presence of a center effect, if confirmed by further investigations, would indicate that a multicenter approach might be required to develop accurate reference equations. In addition, these findings point to the importance, when feasible, of centers comparing their oscillometry results to a local control population, ideally tested at the same center, to determine the applicability of published reference values to the local population. The differences noted between healthy cohorts reinforce the value of current efforts to collate international datasets to produce robust, generalizable GLI reference data for oscillometry. Heather Boas: conceptualization, investigation, writing − original draft, writing − review and editing, funding acquisition, methodology, formal analysis. Joseph McDonough: investigation, resources, writing − review and editing. Adam Lane: formal analysis, writing − review and editing, visualization. Sara B. DeMauro: resources, writing − review and editing, funding acquisition. Clement L. Ren: investigation, writing − review and editing. Maureen Josephson: writing − review and editing. Samuel B. Goldfarb: conceptualization, writing − review and editing, funding acquisition, resources, methodology. Paul D. Robinson: conceptualization, writing − review and editing, resources, methodology. Julian L. Allen: conceptualization, methodology, investigation, writing − original draft, writing − review and editing, funding acquisition, formal analysis, supervision, project administration. The authors thank study coordinators Kris Ziolkowski and Laurie Travaglini. H.B. reports grant funding from the Cystic Fibrosis Foundation (BOAS23D0). SBD reports grant funding from the National Institute of Health (UG3HL137872). S.B.G. reports grant funding from the National Heart, Lung, and Blood Institute (NCT04098445). J.L.A. received funding from the National Heart, Lung, and Blood Institute (NCT04098445), the Morse Foundation, and the Capek Foundation. The authors declare no conflicts of interest. The authors have nothing to report.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Minnesota, Masonic Children's Hospital, Minneapolis, Minnesota, USA.
ORCID-Profile: Heather Boas, Clement L Ren, Samuel B Goldfarb
Förderung
- Cystic Fibrosis Foundation
- National Institute of Health
- NHLBI NIH HHS
- Morse Foundation
- Capek Foundation
- National Heart, Lung, and Blood Institute
Zitieren
APA
Boas, H., McDonough, J., Lane, A., DeMauro, S. B., Ren, C. L., Josephson, M., Goldfarb, S. B., Robinson, P. D., & Allen, J. L. (2026). Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population. Pediatric Pulmonology, 61(3). https://doi.org/10.1002/ppul.71508
Vancouver
Boas H, McDonough J, Lane A, DeMauro SB, Ren CL, Josephson M, et al. Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population. Pediatric Pulmonology. 2026;61(3). doi:10.1002/ppul.71508
BibTeX
@article{Boas2026,
author = {Boas, Heather and McDonough, Joseph and Lane, Adam and DeMauro, Sara B and Ren, Clement L and Josephson, Maureen and Goldfarb, Samuel B and Robinson, Paul D and Allen, Julian L},
title = {Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {3},
doi = {10.1002/ppul.71508}
}
EUVIMED